 SAN FRANCISCO, Sept. 06, 2022 GLOBE NEWSWIRE -- Olema Pharmaceuticals, Inc. Olema, Olema Oncology or the Company, Nasdaq: OLMA, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for womens cancers, today announced that Shane Kovacs, Chief Operating and Financial Officer, will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022, at 2:30 p.m. ET 11:30 a.m. PT. 